FDA Inspection 1151264 — South Florida Institute for Reproductive Medicine

South Florida Institute for Reproductive Medicine — FEI 3007787718

The FDA completed an inspection of South Florida Institute for Reproductive Medicine on September 1, 2021 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Naples, FL (United States)